TTREC, 400 N. Broadway, Smith Building, 5th floor, Baltimore, MD 21231

Visit our Social Pages:

Open

Home
People
Research
Education
News
Videos

The new ‘crystalline shield’ that could end the need for daily insulin.

Home TTREC- Translational Therapeutics & Regenerative Engineering Center / News / The new ‘crystalline shield’ that could end the need for daily insulin.

The new ‘crystalline shield’ that could end the need for daily insulin.

Posted on March 3, 2026

Share

Recent Posts

Immune roles of canonically non-immune cells in biomaterials response
The new ‘crystalline shield’ that could end the need for daily insulin.
Glycoengineering Enriches the Secretome
3D nerve maps pinpoint the path to precision bone repair
Johns Hopkins scientists grow novel “whole-brain” organoid.

Quick Links

Johns Hopkins University
Johns Hopkins Medicine
Johns Hopkins School of Medicine

Recent Posts

Immune roles of canonically non-immune cells in biomaterials responseJune 3, 2026
The new ‘crystalline shield’ that could end the need for daily insulin.March 3, 2026

© 2023 Translational Tissue Engineering Center. All Rights Reserved. | admin login

site by Pendari